Results 11 to 20 of about 301,526 (300)

Combination Vaccines [PDF]

Medical Journal Armed Forces India, 2007
Infections are still a leading cause of morbidity and mortality in children under five years of age, most of which can be prevented by vaccination. However, there are too many vaccines to be administered, increasing the cost of immunization and visits to the paediatrician.
S K, Jatana, Mng, Nair
openaire   +2 more sources

Parenteral vaccination of mammalian livestock with Newcastle disease virus-based vector vaccines offers optimal efficacy and safety [PDF]

, 2011
Newcastle disease virus (NDV) is an avian virus that is being evaluated as a vaccine vector for the delivery of foreign genes in mammals. The use of NDV as a vaccine vector in these species offers two major advantages.
Antonis, A.F.G., Harmsen, M.M., Kortekaas, J.A., Moormann, R.J.M.   +3 more
core   +5 more sources

Combination vaccines

Journal of Global Infectious Diseases, 2011
The combination of diphtheria, tetanus, and pertussis vaccines into a single product has been central to the protection of the pediatric population over the past 50 years. The addition of inactivated polio, Haemophilus influenzae, and hepatitis B vaccines into the combination has facilitated the introduction of these vaccines into recommended ...
David AG Skibinski, Barbara C Baudner, Manmohan Singh, Derek T O′Hagan   +3 more
openaire   +4 more sources

Suspended cell lines for inactivated virus vaccine production

Expert Review of Vaccines, 2023
Introduction Inactivated virus vaccines are the most widely used tool to prevent disease. To meet vaccine production demands, increasing attention has been placed on identifying methods to improve vaccine production efficiency. The use of suspended cells
Jiayou Zhang, Zhenyu Qiu, Siya Wang, Zhenbin Liu, Ziling Qiao, Jiamin Wang, Kai Duan, Xuanxuan Nian, Zhongren Ma, Xiaoming Yang   +9 more
doaj   +1 more source

A case of human rabies with a long incubation period in Wuhan

IDCases, 2021
Rabies remains endemic in China and continues to pose a major threat to public health with a nearly 100 % case fatality rate in humans. We confirmed a case of human rabies in Wuhan, in May 2018.
Meng Shengli, Li Qian, Sun Yan, Wu Wenjuan, Wu Jie, Shi Jinrong, Wang Zejun, Li Xingguo   +7 more
doaj   +1 more source

Screening of potent neutralizing antibodies against SARS-CoV-2 using convalescent patients-derived phage-display libraries

Cell Discovery, 2021
As the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) continues to threaten public health worldwide, the development of effective interventions is urgently needed.
Yongbing Pan, Jianhui Du, Jia Liu, Hai Wu, Fang Gui, Nan Zhang, Xiaojie Deng, Gang Song, Yufeng Li, Jia Lu, Xiaoli Wu, ShanShan Zhan, Zhaofei Jing, Jiong Wang, Yimin Yang, Jianbang Liu, Ying Chen, Qin Chen, Huanyu Zhang, Hengrui Hu, Kai Duan, Manli Wang, Qisheng Wang, Xiaoming Yang   +23 more
doaj   +1 more source

COVID-19 vaccination boosts the potency and breadth of the immune response against SARS-CoV-2 among recovered patients in Wuhan

Cell Discovery, 2022
The immunity of patients who recover from coronavirus disease 2019 (COVID-19) could be long lasting but persist at a lower level. Thus, recovered patients still need to be vaccinated to prevent reinfection by severe acute respiratory syndrome coronavirus
Hong Liang, Xuanxuan Nian, Junzheng Wu, Dong Liu, Lu Feng, Jia Lu, Yan Peng, Zhijun Zhou, Tao Deng, Jing Liu, Deming Ji, Ran Qiu, Lianzhen Lin, Yan Zeng, Fei Xia, Yong Hu, Taojing Li, Kai Duan, Xinguo Li, Zejun Wang, Yong Zhang, Hang Zhang, Chen Zhu, Shang Wang, Xiao Wu, Xiang Wang, Yuwei Li, Shihe Huang, Min Mao, Huanhuan Guo, Yunkai Yang, Rui Jia, Jingwei Xufang, Xuewei Wang, Shuyan Liang, Zhixin Qiu, Juan Zhang, Yaling Ding, Chunyan Li, Jin Zhang, Daoxing Fu, Yanlin He, Dongbo Zhou, Cesheng Li, Jiayou Zhang, Ding Yu, Xiao-Ming Yang   +46 more
doaj   +1 more source

Safety and Immunogenicity of an Inactivated COVID-19 Vaccine, WIBP-CorV, in Healthy Children: Interim Analysis of a Randomized, Double-Blind, Controlled, Phase 1/2 Trial

Frontiers in Immunology, 2022
Safe and effective vaccines against SARS-CoV-2 for children are urgently needed. Here we aimed to assess the safety and immunogenicity of an inactivated COVID-19 vaccine candidate, WIBP-CorV, in participants aged 3-17 years.
Shengli Xia, Kai Duan, Yuntao Zhang, Xiaoqing Zeng, Dongyang Zhao, Huajun Zhang, Zhiqiang Xie, Xinguo Li, Cheng Peng, Wei Zhang, Yunkai Yang, Wei Chen, Xiaoxiao Gao, Wangyang You, Xuewei Wang, Zejun Wang, Zhengli Shi, Yanxia Wang, Xuqin Yang, Qingliang Li, Lili Huang, Qian Wang, Jia Lu, Yongli Yang, Jing Guo, Wei Zhou, Xin Wan, Cong Wu, Wenhui Wang, Shihe Huang, Jianhui Du, Xuanxuan Nian, Tao Deng, Zhiming Yuan, Shuo Shen, Wanshen Guo, Jia Liu, Xiaoming Yang, Xiaoming Yang   +38 more
doaj   +1 more source

Human papillomavirus and HPV vaccines: a review [PDF]

, 2007
Cervical cancer, the most common cancer affecting women in developing countries, is caused by persistent infection with "high-risk" genotypes of human papillomaviruses (HPV). The most common oncogenic HPV genotypes are 16 and 18, causing approximately 70%
Castellsague, X., Claeys, P., Cutts, F. T., de Sanjose, S., Edmunds, W. J., Franceschi, S., Garnett, G., Goldenthal, K. L., Goldie, S., Harper, D. M., Markowitz, L.   +10 more
core   +3 more sources

Safety and immunogenicity of an inactivated SARS-CoV-2 vaccine in healthy adults aged 18 years or older: A randomized, double-blind, placebo-controlled, phase 1/2 trial

EClinicalMedicine, 2021
Background: We aimed to assess the safety and immunogenicity of an inactivated vaccine against COVID-19 in Chinese adults aged ≥18 years. Methods: This is an ongoing randomized, double-blind, placebo-controlled, phase 1/2 clinical trial among healthy ...
Wanshen Guo, Kai Duan, Yuntao Zhang, Zhiming Yuan, Yan-Bo Zhang, Zejun Wang, Dongyang Zhao, Huajun Zhang, Zhiqiang Xie, Xinguo Li, Cheng Peng, Wei Zhang, Yunkai Yang, Wei Chen, Xiaoxiao Gao, Wangyang You, Xue-Wei Wang, Zhengli Shi, Yanxia Wang, Xu-Qin Yang, Lianghao Zhang, Lili Huang, Qian Wang, Jia Lu, Yong-Li Yang, Jing Guo, Wei Zhou, Xin Wan, Cong Wu, Wenhui Wang, Jianhui Du, Xuanxuan Nian, Xing-Hang Li, Shihe Huang, Shuo Shen, Shengli Xia, An Pan, Xiaoming Yang   +37 more
doaj   +1 more source